Cat. No. | Product Name | Field of Application | Chemical Structure |
---|---|---|---|
DC10599 | NSC 409012 Featured |
NSC 409012 is a bioactive chemical.
More description
|
![]() |
DC33622 | CG347B Featured |
CG347B is a biochemical.
More description
|
![]() |
DC10703 | NSC 6038 Featured |
NSC 6038 is a bioactive compound.
More description
|
![]() |
DC10697 | NSC 80538 Featured |
NSC 80538 is a bioactive compound.
More description
|
![]() |
DC9872 | NSC15364 Featured |
NSC15364 is an inhibitor of Shiga Toxin.
More description
|
![]() |
DC12657 | NSC228155 Featured |
NSC228155 is an activator of EGFR. It binds to the sEGFR dimerization domain II and modulates EGFR tyrosine phosphorylation.
More description
|
![]() |
DC9989 | NSC23005 free acid Featured |
NSC23005 is a novel and effective p18 inhibitor (ED50=5.21 nM) in promoting Hematopoietic stem cells (HSCs) expansion in both murine and human models.
More description
|
![]() |
DC8273 | OAC2 Featured |
OAC2 is an Oct4-activating compound which activates expression through the Oct4 gene promoter; enhances reprogramming efficiency by increasing the rate of production of induced pluripotent stem cells (iPSCs) from embryonic fibroblasts; an analog of OAC1.
More description
|
![]() |
DC22380 | NNC 55-0396 2HCl Featured |
NNC 55-0396, Mibefradil derivative, is a highly selective T-type calcium channel blocker; displays IC50 values of 6.8 and > 100 μM for inhibition of Cav3.1 T-type channels and HVA currents respectively in INS-1 cells. IC50 value: 6.8 nMTarget: Cav3.1 T-type channelNNC 55-0396 can be an essential tool in preventing human ovarian cancer cell proliferation as a result of its ability to inhibit the function of T-type Ca2+ channels. It is believed that NNC 55-0396 may functions by dissolving in or passing through the plasma membrane of cells.
More description
|
![]() |
DC1026 | OC000459(Timapiprant) Featured |
OC000459, a Potent, Selective, and Orally Active D Prostanoid Receptor 2 Antagonist.
More description
|
![]() |
DC26028 | RO-3 Featured |
RO-3 is a potent, CNS-penetrant, and orally active P2X3 and P2X2/3 antagonist with pIC50s of 5.9 and 7.0 for human homomultimeric P2X3 and heteromultimeric P2X2/3 receptors, respectively. RO-3 shows selectivity for P2X3 and P2X2/3 over all other functional homomultimeric P2X receptors (IC50 >10 μM at P2X1,2,4,5,7)[1].
More description
|
![]() |
DC12164 | ON-013100 Featured |
ON-013100, an antineoplastic drug, acts a mitotic inhibitor that could inhibit Cyclin D1 expression.
More description
|
![]() |
DC11417 | ONC 212 Featured |
ONC212, a fluorinated-ONC201 analogue, is a promising anti-cancer drug and also a selective agonist of GPR132.
More description
|
![]() |
DC33038 | RO 46-8443 Featured |
RO 46-8443 is the first non-peptide endothelin ETB receptor selective antagonist. RO 46-8443 displays up to 2000-fold selectivity for ETB receptors both in terms of binding inhibitory potency and functional inhibition. The observed parallel rightward shift of concentration-response curves with different antagonist concentrations is consistent with a competitive binding mode. Since R0 46-8443 selectively inhibits ETB receptor mediated responses, it is a valuable tool for clarifying the role of ETB receptors in pathology.
More description
|
![]() |
DC10726 | OPC 21268 Featured |
OPC-21268 is a vasopressin 1 receptor antagonist potentially for the treatment of heart failure and hypertension.
More description
|
![]() |
DC21607 | SB-649868 Featured |
SB-649868 is a potent and selective orally active orexin (OX) 1 and OX2 receptor antagonist (pKi =9.4 and 9.5 at the OX1 and OX2 receptor, respectively).
More description
|
![]() |
DC10702 | OR59402;NSC 48107 Featured |
OR59402;NSC 48107 is a bioactive compound.
More description
|
![]() |
DC10480 | Oxamflatin Featured |
Oxamflatin is a potent inhibitor of histone deacetylases (IC50 = 15.7 nM).
More description
|
![]() |
DC7677 | P7C3-A20 Featured |
P7C3-A20 is an analogue of P7C3,a proneurogenic, neuroprotective agent.
More description
|
![]() |
DC7659 | Palifosfamide Featured |
Palifosfamide is a novel molecule for the treatment of sof tissue sarcoma.
More description
|
![]() |
DC10604 | PARGYLINE HYDROCHLORIDE Featured |
Pargyline is an irreversible inhibitor of monoamine oxidase (MAO; Kis = 15 and 1.8 μM for MAO-A and MAO-B, respectively).
More description
|
![]() |
DC10893 | Parimifasor Featured |
Parimifasor is an immunomodulator, with anti-inflammatory activity.
More description
|
![]() |
DC9865 | Paulownin Featured |
Paulownin can highly inhibit the growth of H. pylori and exhibits strong inhibitory specificity against H. pylori related to E. coli.
More description
|
![]() |
DC8844 | PCI-27483 Featured |
PCI-27483 is a selective small molecule inhibitor of activated coagulation factor VII (FVIIa), which is in preclinical development as a novel anti-cancer agent.
More description
|
![]() |
DC9744 | PD0166285 Featured |
PD0166285 is a potent Wee1 and Chk1 inhibitor with activity at nanomolar concentrations.PD0166285 is a novel G2 checkpoint abrogator.
More description
|
![]() |
DC10904 | PDM2 Featured |
PDM 2 is an analog of resveratrol acting as a potent and selective aryl hydrocarbon receptor (AhR) antagonist, with a Ki of 1.2 nM.
More description
|
![]() |
DC10507 | Pentamidine dihydrochloride Featured |
Pentamidine Dihydrochloride(MP601205 dihydrochloride) is an antimicrobial agent.
More description
|
![]() |
DC23998 | BMX-IN-1 Featured |
BMX-IN-1 is a selective, irreversible inhibitor of bone marrow tyrosine kinase on chromosome X (BMX) that targets Cys496 in the BMX ATP binding domain with an IC50 of 8 nM, also targets the related Bruton’s tyrosine kinase (BTK) with an IC50 value of 10.4 nM, but is more than 47-656-fold less potent against Blk, JAK3, EGFR, Itk, or Tec activity.
More description
|
![]() |
DC26069 | SR-11237 Featured |
SR-11237 is a selective pan retinoid X receptor (RXR) agonist with no retinoid A receptor (RAR) activity. .
More description
|
![]() |
DC8112 | Pirarubicin(THP) Featured |
Pirarubicin is an analogue of the anthracycline anti-neoplastic doxorubicin, which is an inhibitor of Topo II.
More description
|
![]() |